...
首页> 外文期刊>Cancer Management and Research >Independent Risk Factors of Early Recurrence After Curative Resection for Perihilar Cholangiocarcinoma: Adjuvant Chemotherapy May Be Beneficial in Early Recurrence Subgroup
【24h】

Independent Risk Factors of Early Recurrence After Curative Resection for Perihilar Cholangiocarcinoma: Adjuvant Chemotherapy May Be Beneficial in Early Recurrence Subgroup

机译:针刺胆管癌治疗切除后早期复发的独立危险因素:辅助化疗在早期复发亚组中可能是有益的

获取原文
           

摘要

Purpose:In current clinical practice, early recurrence (ER) is not commonly discussed in perihilar cholangiocarcinoma (pCCA), and its risk factors for this disease have not been well clarified. We carried out this study to analyze the risk factors contributing to ER and explored the prognostic factors after curative resection for pCCA.Patients and Methods:A total of 335 consecutive pCCA patients were retrospectively analyzed. Risk factors contributing to ER were evaluated using univariate and multivariate logistic regression analyses. Prognostic factors of the ER group were determined by univariate and multivariate Cox regression models. The overall survival (OS) rate was calculated using the Kaplan-Meier method. The Log rank test was used for OS comparison.Results:Of the 335 cases, 258 patients (77.0%) developed tumor recurrence, 136 patients (40.6%) developed ER, and 122 patients (36.4%) developed late recurrence (LR) postoperatively. The median OS of the ER and LR groups was 15 months and 36 months, respectively (P0.001). The multivariate analysis revealed that poor pathological differentiation (P=0.006; moderate vs well, odds ratio [OR]=2.162, 95% confidence interval [CI] 0.753-6.208, P=0.152; poor vs well, OR=4.839, 95% CI 1.544-15.170, P=0.007), perineural invasion (OR=4.797, 95% CI 1.586-14.510, P=0.005), and high levels of preoperative carbohydrate antigen 19-9 (CA19-9) (OR=2.205, 95% CI 1.208-4.026, P=0.010) were independent risk factors of developing ER after resection. Adjuvant chemotherapy (HR=0.383, 95% CI 0.154-0.953, P=0.039) remained as the independent protective factor of OS in patients with ER.Conclusion:It is recommended that patients with poorly differentiated tumors, presence of perineural invasion, and high levels of preoperative CA19-9 receive closer follow-up and adjuvant chemotherapy following surgery.? 2020 Zhao et al.
机译:目的:在目前的临床实践中,早期复发(ER)在Periwilar胆管癌(PCCA)中不一定讨论,其对这种疾病的危险因素并未澄清。我们开展了本研究,分析了对ER的危险因素,并探讨了PCCA的治疗切除后的预后因素.PCO.APAtient和方法:回顾性分析了335名连续的PCCA患者。使用单变量和多变量逻辑回归分析进行评估对ER有贡献的危险因素。通过单变量和多变量COX回归模型确定ER组的预后因素。使用Kaplan-Meier方法计算总生存率(OS)速率。日志等级测试用于OS比较。结果:335例,258例患者(77.0%)发育肿瘤复发,136名患者(40.6%)发达的ER,122名患者(36.4%)术后发育了晚期复发(LR) 。 ER和LR组的中位OS分别为15个月和36个月(P <0.001)。多变量分析显示,病理分化差(P = 0.006;中等VS孔,差比[或] = 2.162,95%置信区间[CI] 0.753-6.208,P = 0.152;差Vs良好,或= 4.839,95% CI 1.544-15.170,p = 0.007),麻纹侵袭(或= 4.797,95%CI 1.586-14.510,P = 0.005),以及高水平的术前碳水化合物抗原19-9(或= 2.205,95 %CI 1.208-4.026,P = 0.010)是切除后开发ER的独立风险因素。佐剂化疗(HR = 0.383,95%CI 0.154-0.953,P = 0.039)仍然是OS中OS的独立保护因子。结论:建议患有肿瘤差异不良的患者,存在的侵袭侵袭和高术前CA19-9的水平接近手术后的近后续和佐剂化疗。? 2020 Zhao等。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号